GPT Analysis

Empower Your Investments! Unleash the Potential with Smart Stock Analysis!

United States Hong Kong China Singapore Japan India
Sorting Arrows
Symbol
▲ ▼
Company Name Rating
▲ ▼
Recommendation
▲ ▼
Evaluation from GPT Action Time
▲ ▼
00788 CHINA TOWER 75 Positive Based on the provided financial indicators, 0788.HK appears to be a potentially good investment option. The stock has been trading near its day high and the previous close. The average daily volume is relatively high, indicating active trading in the stock. The market capitalization is also significant, suggesting the company's size and stability. The stock has shown a positive year change, indicating potential growth. However, it is essential to note that the two-hundred-day average is lower than the current price, indicating that the stock may be overvalued. Additionally, the year-low price is considerably lower than the current price, suggesting that the stock has already experienced a significant increase. It would be advisable to conduct further research on the company's financials, industry trends, and news before making an investment decision.

2024-04-02 10:21:31
02823 ISHARES A50 50 Negative Based on the analysis of the key financial indicators for 2823.HK, it is evident that the stock's year change is -0.11134906453468386, indicating a negative performance in the past year. Additionally, the stock's two hundred day average is 12.663850002288818, which is higher than the current last price of 12.489999771118164. This suggests that the stock has been experiencing a downward trend. Moreover, the year high of 14.75 and year low of 10.9399995803833 indicate a relatively narrow price range over the past year.

Considering these factors, I would rate the stock with a rating of 50 out of 100. The negative year change and downward trend indicates some level of risk associated with this investment. However, further analysis should be conducted to better understand the company's financial health and future prospects.

2024-03-15 07:40:14
02628 CHINA LIFE 50 Neutral 2628.HK is a stock listed on the Hong Kong Stock Exchange. The stock has a market capitalization of HKD 703.7 billion, making it a large-cap stock. The stock's previous close was HKD 9.81, and it is currently trading at HKD 9.51. The stock has a 52-week range of HKD 8.19 to HKD 15.84. Over the past year, the stock has declined by approximately 23.48%. The stock's 50-day average price is HKD 9.36, which indicates a slight upward trend. The stock's two hundred-day average price is HKD 11.24. Based on these indicators, the stock seems to be in a downward trend. The stock's trading volume has been relatively high, with an average volume of 29.45 million shares over the past three months. Given the stock's performance and market trends, I would rate the stock as neutral and suggest further analysis before making any investment decisions.

2024-03-15 07:40:11
00941 CHINA MOBILE 80 Positive Stock 0941.HK is listed on the Hong Kong Stock Exchange (HKG) and is denominated in Hong Kong Dollars (HKD). It has a market capitalization of HKD 1,457,387,317,760.0 and a total of 21,998,299,136 shares outstanding. The stock has a year-to-date return of 3.57% and its year high and year low prices are HKD 70.20 and HKD 60.90, respectively. The stock currently trades at HKD 66.25, with a day high and day low of HKD 66.80 and HKD 66.00, respectively. The 50-day and 200-day moving averages are HKD 66.36 and HKD 64.66, respectively. The stock has a regular market volume of 18,889,840 shares and a ten-day average volume of 21,269,332 shares. Based on these financial indicators, it can be concluded that the stock has been performing reasonably well and could be a potential investment option.

2024-03-15 07:38:51
00386 SINOPEC CORP 75 Positive Based on the given financial indicators, 0386.HK is a stock worth considering for investment. The stock has a relatively stable average trading volume over the past three months, indicating a consistent level of market interest. Additionally, the stock's year-to-date performance shows a slight negative change (-0.22%), but this can be considered within an acceptable range. The stock's market capitalization is also quite significant, indicating its prominence and stability in the market. Furthermore, despite a relatively high year-to-date high of 5.47 HKD, the current price (4.55 HKD) is still within a reasonable range. Therefore, considering these factors, the sentiment is positive for investing in 0386.HK. The rating for this stock can be considered at around 75, suggesting that it's a relatively good option for investors.

2024-03-15 07:38:23
00001 CKH HOLDINGS 30 Negative Based on the provided financial indicators, the stock of 0001.HK appears to be experiencing a decline in its price year to date, currently trading below its 200-day moving average. The year change is negative, indicating a decrease in value over the past year. The market capitalization is relatively large, suggesting it is a significant player in the market. The volume of shares traded is relatively high, indicating interest from investors. The stock's last price is below the fifty-day average, suggesting a short-term downward trend. Overall, the stock performance is not favorable, and it is not recommended for investment at this point.

2024-03-06 06:58:40
03988 BANK OF CHINA 80 Positive 3988.HK is a stock listed on the Hong Kong Stock Exchange. It has a market capitalization of HKD 1.3 trillion, indicating its large size and stability. Over the past year, the stock has shown a positive year change of 1.33%, suggesting a favorable performance. The stock's year high was HKD 3.45, and the year low was HKD 2.60, indicating a moderate level of volatility. The stock's last price was HKD 3.09, which is higher than the previous close, indicating a positive momentum. The fifty-day average is HKD 2.97, while the two-hundred-day average is HKD 2.89. This shows a positive trend for the stock over the short and long term. The stock has a high trading volume, with an average of 227 million shares traded over the past three months. Overall, the stock shows positive indicators and may be considered a worthwhile investment.

2024-03-06 06:58:17
01091 SOUTH MANGANESE 35 Negative Based on the given financial indicators, the stock 1091.HK seems to be experiencing a downturn. The year change is negative at -59.02%, indicating a decline in value over the past year. The stock's year high of 0.64 HKD and year low of 0.17 HKD also suggest a significant volatility. The two hundred day average of 0.47 HKD is considerably higher than the current price of 0.24 HKD, which implies that the stock may be undervalued. However, the fifty day average of 0.39 HKD is still higher than the current price, indicating a potential ongoing decline. The stock has a market cap of 833,115,790.23 HKD, which may raise concerns regarding its liquidity and stability. Furthermore, the stock's trading volume has been relatively low, with the ten-day average volume at 17,518,666 shares. Considering these factors, it is advisable to approach investing in this stock with caution.

2024-03-06 06:58:14
00883 CNOOC 85 Positive Based on the provided financial indicators, 0883.HK appears to be a promising investment option. The stock has shown a positive year change of 34.57% and has been trading consistently above its fifty-day and two-hundred-day average prices, indicating bullish momentum. Furthermore, the stock has a relatively high market capitalization of HKD 833,138,017,454, emphasizing its stability and potential for growth. The trading volume has also been consistently high, indicating a strong interest from investors. Despite a recent pullback in price, the stock is still trading near its year high, suggesting a positive outlook. Considering these factors, it is fair to rate 0883.HK with a rating of 85 out of 100 as it shows strong potential for future gains.

2024-03-06 06:58:08
01033 SINOPEC SSC 40 Negative Based on the provided financial indicators, the stock 1033.HK is currently trading at HKD 0.4749, with a market capitalization of HKD 29,703,696,625.67. The stock has a fifty-day average of HKD 0.4673 and a two-hundred-day average of HKD 0.5436. The year change for the stock is -26.92%. The year high for the stock is HKD 0.71, while the year low is HKD 0.415. The stock has a moderate trading volume, with a ten-day average volume of 4,289,200 shares and a three-month average volume of 4,323,190 shares. Based on these indicators, the stock's performance has been declining over the year, with a lower than average trading volume. Therefore, in terms of investment, the sentiment is negative and the rating is relatively low (around 40) due to the stock's poor performance compared to its previous high levels.

2024-03-06 06:57:49
02162 KEYMED BIO-B 30 Negative The stock with symbol 2162.HK is currently trading at a price of HKD 39.30. It had a day high of HKD 40.40 and a day low of HKD 38.15. The fifty-day average for this stock is HKD 50.79, while the two-hundred-day average is HKD 51.81. The stock's market capitalization is approximately HKD 10.87 billion. Over the past year, the stock has experienced a negative year change of -0.39%. The year high for the stock was HKD 82.85, while the year low was HKD 37.30. Based on these indicators, the stock's performance has been relatively weak, as it has declined from its previous close of HKD 40.85. With a negative year change and a decline from the previous close, the sentiment for this stock is negative. Considering these factors, I would not recommend investing in this stock at the moment.

2024-01-17 03:18:59
02162 KEYMED BIO-B 30 Negative The stock with symbol 2162.HK is currently trading at a price of HKD 39.30. It had a day high of HKD 40.40 and a day low of HKD 38.15. The fifty-day average for this stock is HKD 50.79, while the two-hundred-day average is HKD 51.81. The stock's market capitalization is approximately HKD 10.87 billion. Over the past year, the stock has experienced a negative year change of -0.39%. The year high for the stock was HKD 82.85, while the year low was HKD 37.30. Based on these indicators, the stock's performance has been relatively weak, as it has declined from its previous close of HKD 40.85. With a negative year change and a decline from the previous close, the sentiment for this stock is negative. Considering these factors, I would not recommend investing in this stock at the moment.

2024-01-17 03:18:59
02162 KEYMED BIO-B 30 Negative The stock with symbol 2162.HK is currently trading at a price of HKD 39.30. It had a day high of HKD 40.40 and a day low of HKD 38.15. The fifty-day average for this stock is HKD 50.79, while the two-hundred-day average is HKD 51.81. The stock's market capitalization is approximately HKD 10.87 billion. Over the past year, the stock has experienced a negative year change of -0.39%. The year high for the stock was HKD 82.85, while the year low was HKD 37.30. Based on these indicators, the stock's performance has been relatively weak, as it has declined from its previous close of HKD 40.85. With a negative year change and a decline from the previous close, the sentiment for this stock is negative. Considering these factors, I would not recommend investing in this stock at the moment.

2024-01-17 03:18:59
02162 KEYMED BIO-B 30 Negative The stock with symbol 2162.HK is currently trading at a price of HKD 39.30. It had a day high of HKD 40.40 and a day low of HKD 38.15. The fifty-day average for this stock is HKD 50.79, while the two-hundred-day average is HKD 51.81. The stock's market capitalization is approximately HKD 10.87 billion. Over the past year, the stock has experienced a negative year change of -0.39%. The year high for the stock was HKD 82.85, while the year low was HKD 37.30. Based on these indicators, the stock's performance has been relatively weak, as it has declined from its previous close of HKD 40.85. With a negative year change and a decline from the previous close, the sentiment for this stock is negative. Considering these factors, I would not recommend investing in this stock at the moment.

2024-01-17 03:18:59
00388 HKEX 80 Positive Hong Kong Exchanges and Clearing Limited (0388.HK) is a leading financial services company in the Financial Data & Stock Exchanges sector. It operates the Hong Kong Stock Exchange, the third-largest stock exchange in Asia by market capitalization. The company has a strong financial position with a market capitalization of HKD 361.59 billion and total cash of HKD 138.91 billion. It has a trailing P/E ratio of 31.34 and a forward P/E ratio of 27.48, indicating that the stock may be slightly overvalued. The company has a dividend yield of 3.16% and a payout ratio of 78.38%. Its earnings have been growing at a rate of 30.5% and its revenue has grown by 18.8% in the last fiscal year. Overall, the stock has a positive sentiment and a rating of 80, indicating that it is a good investment option.

2023-10-22 10:54:34
00388 HKEX 80 Positive Hong Kong Exchanges and Clearing Limited (0388.HK) is a leading financial services company in the Financial Data & Stock Exchanges sector. It operates the Hong Kong Stock Exchange, the third-largest stock exchange in Asia by market capitalization. The company has a strong financial position with a market capitalization of HKD 361.59 billion and total cash of HKD 138.91 billion. It has a trailing P/E ratio of 31.34 and a forward P/E ratio of 27.48, indicating that the stock may be slightly overvalued. The company has a dividend yield of 3.16% and a payout ratio of 78.38%. Its earnings have been growing at a rate of 30.5% and its revenue has grown by 18.8% in the last fiscal year. Overall, the stock has a positive sentiment and a rating of 80, indicating that it is a good investment option.

2023-10-22 10:54:34
09885 YSB 50 Negative YSB Inc. (9885.HK) is a pharmaceutical retailer based in China. The company operates in the healthcare sector and has a market capitalization of HKD 35,364,757,504. YSB Inc. has a negative profit margin of -25.91% and a trailing EPS of -6.71. The company's revenue growth rate is 18.6% and it has a gross margin of 10.5%. YSB Inc. has a high debt-to-equity ratio of 9.87, which indicates a higher level of financial risk. However, the company has a strong liquidity position with a current ratio of 1.514 and a quick ratio of 0.746. YSB Inc. has a price-to-sales ratio of 2.28 and a price-to-book ratio of 19.52. Considering the negative profit margin and high debt-to-equity ratio, it is recommended to approach this investment with caution.

2023-10-17 11:52:05
09885 YSB 50 Negative YSB Inc. (9885.HK) is a pharmaceutical retailer based in China. The company operates in the healthcare sector and has a market capitalization of HKD 35,364,757,504. YSB Inc. has a negative profit margin of -25.91% and a trailing EPS of -6.71. The company's revenue growth rate is 18.6% and it has a gross margin of 10.5%. YSB Inc. has a high debt-to-equity ratio of 9.87, which indicates a higher level of financial risk. However, the company has a strong liquidity position with a current ratio of 1.514 and a quick ratio of 0.746. YSB Inc. has a price-to-sales ratio of 2.28 and a price-to-book ratio of 19.52. Considering the negative profit margin and high debt-to-equity ratio, it is recommended to approach this investment with caution.

2023-10-17 11:52:05
01833 PA GOODDOCTOR 50 Negative Ping An Healthcare and Technology Company Limited (1833.HK) is a healthcare information services company based in China. The company operates in the healthcare sector and has a market capitalization of HKD 20,586,102,784. With a beta of 0.75783, the stock is less volatile compared to the overall market. The company's financial indicators show a negative profit margin of -0.07021 and a negative trailing EPS of -0.39. The company has a high overall risk rating of 9, indicating potential risks associated with its operations. The stock has a 52-week high of HKD 34.2 and a 52-week low of HKD 13.5. Based on the financial indicators and risk profile, it is recommended to approach this investment with caution.

2023-10-12 05:06:10
01833 PA GOODDOCTOR 50 Negative Ping An Healthcare and Technology Company Limited (1833.HK) is a healthcare information services company based in China. The company operates in the healthcare sector and has a market capitalization of HKD 20,586,102,784. With a beta of 0.75783, the stock is less volatile compared to the overall market. The company's financial indicators show a negative profit margin of -0.07021 and a negative trailing EPS of -0.39. The company has a high overall risk rating of 9, indicating potential risks associated with its operations. The stock has a 52-week high of HKD 34.2 and a 52-week low of HKD 13.5. Based on the financial indicators and risk profile, it is recommended to approach this investment with caution.

2023-10-12 05:06:10